"10.1371_journal.pone.0118627","plos one","2015-03-13T00:00:00Z","Syed Faraz Kazim; Maria del Carmen Cardenas-Aguayo; Mohammad Arif; Julie Blanchard; Fatima Fayyaz; Inge Grundke-Iqbal; Khalid Iqbal","Inge Grundke-Iqbal Research Floor, Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities (NYSIBR), Staten Island, New York, United States of America; Neural and Behavioral Science Graduate Program, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States of America; SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN), Staten Island, New York, United States of America","Conceived and designed the experiments: SFK IGI KI. Performed the experiments: SFK MDCC MA JB FF. Analyzed the data: SFK MDCC MA JB. Contributed reagents/materials/analysis tools: SFK IGI KI. Wrote the paper: SFK KI.","This study was partly supported by EVER NeuroPharma GmbH, Unterach, Austria. Based on studies described in this manuscript, the authors submitted a patent application to the United States Patent and Trademark Office on 12/11/2014, entitled: Treatment of Autism Spectrum Disorders with Ciliary Neurotrophic Factor Peptide Mimetic; application number US62/083,570; Inventors: Khalid Iqbal and Inge Grundke-Iqbal. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2015","03","Syed Faraz Kazim","SFK",7,TRUE,3,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
